These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13417541)

  • 21. [Problem of cancer of the prostate. II. Principles and practice of endocrine therapy; immediate results; treated cancer; new clinical data].
    HAIMOVICI JL
    Med Gen Fr; 1951 Dec; 11(12):221-5. PubMed ID: 14909709
    [No Abstract]   [Full Text] [Related]  

  • 22. [Five years of medical therapy of cancer of the prostate; clinico-statistical findings].
    ARRIGONI G; CHIEREGO F
    G Ital Chemioter; 1956; 3(3-4):575-7. PubMed ID: 13462212
    [No Abstract]   [Full Text] [Related]  

  • 23. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormone therapy in prostatic cancer.
    Smith PH; Akdas A; Mason MK; Richards B; Robinson MR; de Pauw M; Sylvester R
    Acta Urol Belg; 1980 Jan; 48(1):98-105. PubMed ID: 7001876
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hormone therapy in prostatic cancer].
    Marberger H; Madersbacher H
    Verh Dtsch Ges Inn Med; 1967; 73():518-36. PubMed ID: 5591803
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hormono- therapy of cancer of the prostate].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():181-91. PubMed ID: 5485068
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antirheumatic effect of cafestrol; evaluation of its so-called cortisone-like properties].
    PIOTTI LE
    Reumatismo; 1954; 6(1):48-63. PubMed ID: 13167530
    [No Abstract]   [Full Text] [Related]  

  • 28. Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancer.
    Vetto JT; Beer TM; Fidda N; Ham B; Jimenez-Lee R; Schmidt W
    Diagn Cytopathol; 2004 Dec; 31(6):417-9. PubMed ID: 15540181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisone treatment in advanced carcinoma of the prostate.
    MILLER GM; HINMAN F
    Trans West Sect Am Urol Assoc; 1953; 20():117-28. PubMed ID: 13179273
    [No Abstract]   [Full Text] [Related]  

  • 31. [Excretion of hormones in patients with cancer of the breast after hormone loading with synestrol and cortisone].
    Olinia AIa
    Klin Lech Zlokach Novoobraz; 1968; 11():93-104. PubMed ID: 5725418
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current treatment of cancer of the prostate].
    Durand L
    Lyon Chir; 1966 Sep; 62(5):763-6. PubMed ID: 5974887
    [No Abstract]   [Full Text] [Related]  

  • 33. Arrest of hormone-dependent cancer by pituitary-adrenal inhibition.
    LEMON HM; REYNOLDS MM; WOTIZ HH
    BMQ; 1955 Mar; 6(1):8-13. PubMed ID: 14378098
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of prostate carcinoma].
    RICKLIN P
    Helv Chir Acta; 1955 Apr; 22(2):111-26. PubMed ID: 14380933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Remarks on hormonal treatment of prostatic canecer].
    Verrière P; Burlet P
    J Med Lyon; 1967 May; 48(121):869-70. PubMed ID: 5616975
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical management in the presence of cancer of the prostate].
    Cereseto PL
    Rev Asoc Med Argent; 1965 Jul; 79(7):346-8. PubMed ID: 5853394
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aplastic anemia after estrogen implantation in man with cancer of prostate].
    FIEHRER A
    Rev Pathol Gen Physiol Clin; 1958 May; 58(698):789-92. PubMed ID: 13579838
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proton hypophysectomy and subtotal body irradiation in combined treatment of stage IV prostate cancer].
    Aleksandrov VP; Kondrat'eva EA; Karelin MI; Konnov BA; Zharinov GM; Metelev VV; Pecherskiĭ AV
    Urologiia; 1999; (6):26-8. PubMed ID: 16859000
    [No Abstract]   [Full Text] [Related]  

  • 39. Percentage of positive biopsy cores at the onset of hormone therapy for prostate cancer: prognostic significance.
    Normand G; Celhay O; Briffaux R; Pirès C; Doré B; Fromont G; Irani J
    Urol Int; 2009; 83(2):160-5. PubMed ID: 19752610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remote results of cortisone therapy of prostatic cancer].
    CICCARELLI G
    Arch Med Interna; 1954; 6():41-53. PubMed ID: 13276175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.